Pirmitegravir
Pirmitegravir (STP0404) is a potent and selective inhibitor of allosteric integrase (ALLINI) targeting the LEDGF/p75 binding site. Pirmitegravir inhibits PBMC. Pirmitegravir inhibits PBMC.Pirmitegravir has significant antiviral activity and may be useful in the study of HIV virus infection.
Product Specifications
CAS Number
2245231-10-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
495.01
Molecular Formula
C27H31ClN4O3
Notes
Research use only, not for human use.
Receptor
HIV Protease
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS520913-02 5x 0.05 mg
Anti-Rainbow Trout TNF alpha, HRPO, (Polyclonal) (Goat IgG)
Ask
View Details 
MBS1322641-01 0.02 mg (E-Coli)
Recombinant Danio rerio Regulator of G-protein signaling 7-binding protein B (rgs7bpb)
Ask
View Details MBS1322641-02 0.1 mg (E-Coli)
Recombinant Danio rerio Regulator of G-protein signaling 7-binding protein B (rgs7bpb)
Ask
View Details